Vimarsana
Biggest News Aggregation in the World

Christoph Rischpler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christoph Rischpler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christoph Rischpler Today - Breaking & Trending Today

How Early Can Imaging Assess Response in End-Stage Prostate Cancer? - Vimarsana News

How Early Can Imaging Assess Response in End-Stage Prostate Cancer?

Published: October 24, 2022

177Lu-PSMA SPECT at cycle three (week 12) of six cycles of PSMA-targeted treatment predicted progression-free survival for men with end-stage metastatic castration-resistant prostate cancer.

Source: medscape.com
Related Topics:
United StatesNew South WalesComunidad Autonoma De CatalunaLos AngelesKen HerrmannAndrei GafitaChristoph RischplerLouise EmmettUniversity Of DuisburgJonsson Comprehensive Cancer CenterEuropean Association Of Nuclear MedicineEuropean AssociationNuclear MedicineHospital SydneyMedscape MedicalMedscape Medical NewsComprehensive Cancer CenterRadiation SensitizerDrug AdministrationDetermine Treatment SuccessFailure EarlierPrediction After Two TreatmentsSingle Photon Computed TomographyIological MarkerPositron Emission Tomography Pet
PSMA PET Imaging More Accurate Than CT in Detecting Hepatocellular Carcinoma - Vimarsana News

PSMA PET Imaging More Accurate Than CT in Detecting Hepatocellular Carcinoma

Published: September 30, 2021

Reston, VA-PSMA (prostate-specific membrane antigen) PET/CT is more accurate than conventional CT in the detection of hepatocellular carcinoma

Source: miragenews.com
Related Topics:
Wolfgang FendlerCatherine LeyhNader HirmasWolfgangp FendlerLale UmutluManuel WeberJustin FerdinandusMiriam SraiebMichael NaderKen HerrmannHeiner WedemeyerFrancesco BarbatoChristoph RischplerJournal Of Nuclear MedicineDepartment Of GastroenterologyEssen University Hospital InGerman Cancer ConsortiumUniversity Hospital EssenUniversity DuisburgUniversity Of DuisburgDepartment Of Nuclear MedicineEssen University HospitalPedro Fragoso CostaNuclear MedicineUniversity Duisburg Essen